Literature DB >> 20731951

[The randomized, multicenter, controlled clinic trail for treating advanced non-small cell lung cancer with combined traditional chinese medicine and vinorelbine (Navelbine, NVB) plus cisplatin (DDP) chemotherapy.].

Yanzhi Chen1, Lijun Di, Shulan Zhang, Maosen Chen, Hong Sun, Fei Gao, Ying Zhang, Pingping Li.   

Abstract

Entities:  

Year:  2008        PMID： 20731951     DOI： 10.3779/j.issn.1009-3419.2008.03.003

Source DB:  PubMed          Journal:  Zhongguo Fei Ai Za Zhi        ISSN： 1009-3419


× No keyword cloud information.
  4 in total

Review 1.  Recent highlights of Chinese medicine for advanced lung cancer.

Authors:  Xi-Ran He; Shu-Yan Han; Ping-Ping Li
Journal:  Chin J Integr Med       Date:  2016-12-27       Impact factor: 1.978

2.  Longer overall survival in a patient with advanced non-small cell lung cancer treated with Chinese medicine and chemotherapy.

Authors:  Yan-Zhi Chen; Zhan-Dong Li; Ning Zhou; Hong Sun; Ping-Ping Li
Journal:  Chin J Integr Med       Date:  2012-08-02       Impact factor: 1.978

3.  Clinical study on long-term overall survival of advanced non-small-cell lung cancer patients treated with Chinese medicine and Western medicine.

Authors:  Yan-zhi Chen; Xiao-bing Feng; Zhan-dong Li; Wen-xian Zheng; Hong Sun; Ping-ping Li
Journal:  Chin J Integr Med       Date:  2014-03-04       Impact factor: 1.978

Review 4.  The efficacy of Chinese herbal medicine as an adjunctive therapy for advanced non-small cell lung cancer: a systematic review and meta-analysis.

Authors:  Shi Guang Li; Hai Yong Chen; Chen Sheng Ou-Yang; Xi-Xin Wang; Zhen-Jiang Yang; Yao Tong; William C S Cho
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.